Liposomal formulation of glycosphingolipids from Sphingomonas paucimobilis induces antitumour immunity in mice. (14th September 2018)

• Record Type: Journal Article
• Authors: Khan, Masood A.; Aljarbou, Ahmed N.; Aldebasi, Yousef H.; Alorainy, Mohammed S.; Rahmani, Arshad H.; Younus, Hina; Khan, Arif
• Is Part Of: Journal of drug targeting. Volume 26:Number 8(2018)
• Page Start: 709
• Page End: 719
• Publication Date: 2018-09-14
• Subjects: Glycosphingolipids -- NKT cells -- immunotherapy -- liposomes; Drug delivery systems -- Periodicals; Drug Delivery Systems; Vehicles; Drug Administration Routes; Drug Evaluation; 615.7
• DOI: 10.1080/1061186X.2018.1424857
• Languages: English
• ISSNs: 1061-186X

Abstract

Abstract: Natural Killer T (NKT) cells play an important role in host's anti-tumour immune response. Glycosphingolipids (GSLs) isolated from Sphingomonas paucimobilis have the ability to stimulate NKT cells. In this study, the activity of free GSLs or GSLs-incorporated liposomes (glycosphingosomes) was investigated against dimethyl-α-benzanthracene (DMBA)-induced tumours in mice. The anti-tumour immunity of GSLs- or glycosphingosomes-loaded bone marrow-derived dendritic cells (BMDCs) was investigated in tumour-bearing mice. The Immunotherapeutic potential of co-administration of liposomal doxorubicin (Lip-Dox) and GSLs or glycosphingosomes was assessed by measuring cytokine levels and VEGF in the tumour tissues. Pretreatment with glycosphingosomes significantly delayed the frequency of tumour formation. Immunotherapy with glycosphingosomes-loaded BMDCs increased serum IFN-γ level and survival rate in mice. The effect of immunotherapy was dependent on effector functions of NK cells because the depletion of NK cells abolished the effects of immunotherapy. There was reduced tumour growth with low expression of VEGF in the group of mice treated with glycosphingosomes and Lip-Dox combination. Moreover, the splenocytes secreted higher levels of IFN-γ, IL-12 and lower TGF-β level. The results of this study indicate that glycosphingosomes can induce better antitumour immunity and may be considered a novel formulation in antitumour therapy.